BioCryst Pharmaceuticals
BCRX
#4719
Rank
A$2.57 B
Marketcap
$12.43
Share price
0.65%
Change (1 day)
39.48%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Cash on Hand

Cash on Hand as of September 2024 : A$0.53 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has A$0.53 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioCryst Pharmaceuticals - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.57 B-8.43%
2022-12-31A$0.62 B-10.95%
2021-12-31A$0.70 B79.24%
2020-12-31A$0.39 B100.77%
2019-12-31A$0.19 B31.21%
2018-12-31A$0.14 B1.2%
2017-12-31A$0.14 B93.27%
2016-12-31A$75.81 M7.11%
2015-12-31A$70.78 M-20.4%
2014-12-31A$88.92 M108.42%
2013-12-31A$42.66 M24.54%
2012-12-31A$34.25 M-15.8%
2011-12-31A$40.68 M-23.39%
2010-12-31A$53.1 M-30.82%
2009-12-31A$76.77 M-11.97%
2008-12-31A$87.21 M50.39%
2007-12-31A$57.98 M22.04%
2006-12-31A$47.51 M-30.82%
2005-12-31A$68.68 M129.39%
2004-12-31A$29.94 M11.14%
2003-12-31A$26.94 M-37.91%
2002-12-31A$43.39 M-30.77%
2001-12-31A$62.67 M42.25%
2000-12-31A$44.06 M25.34%
1999-12-31A$35.15 M75%
1998-12-31A$20.08 M244.41%
1997-12-31A$5.83 M28.71%
1996-12-31A$4.53 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.26 B 137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.92 B 263.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.22 M-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.46 B 175.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$8.10 B 1,426.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.21 B 129.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.92 B 1,202.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$0.24 B-54.58%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.61 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA